These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 122074)

  • 1. Pharmacological activity of some pyrazolo[1,5-a]pyrimidines.
    Pirisino R; Pecori Vettori L
    Farmaco Sci; 1979 Sep; 34(9):802-7. PubMed ID: 122074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Further investigations on the antinflammatory activity of some 2-phenylpyrazolol [1,5-a]pyrimidine compounds.
    Pirisino R; Mangano G; Ceppatelli P; Corrias M; Ignesti G; Carla V; Vettori LP
    Farmaco Sci; 1981 Aug; 36(8):682-91. PubMed ID: 6791962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new pyrazolo pyrimidine derivative inhibitor of cyclooxygenase-2 with anti-angiogenic activity.
    Devesa I; Alcaraz MJ; Riguera R; Ferrándiz ML
    Eur J Pharmacol; 2004 Mar; 488(1-3):225-30. PubMed ID: 15044055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pyrazolo[3,4-d]pyrimidine derivatives as COX-2 selective inhibitors: synthesis and molecular modelling studies.
    Raffa D; Maggio B; Plescia F; Cascioferro S; Raimondi MV; Plescia S; Cusimano MG
    Arch Pharm (Weinheim); 2009 Jun; 342(6):321-6. PubMed ID: 19479756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological activity of some pyrrolo and pyrazolo pyrimidine derivatives.
    Perretti F; Pirisino R; Pecori Vettori L; Auzzi G; Bruni F; Costanzo A; Matucci M; Longo G; Messori A
    Farmaco Sci; 1987 Nov; 42(11):793-804. PubMed ID: 3502090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel 3-alkoxy-1H-pyrazolo[3,4-d]pyrimidines as EGFR and erbB2 receptor tyrosine kinase inhibitors.
    Ducray R; Ballard P; Barlaam BC; Hickinson MD; Kettle JG; Ogilvie DJ; Trigwell CB
    Bioorg Med Chem Lett; 2008 Feb; 18(3):959-62. PubMed ID: 18182285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Synthesis of pyrazole derivatives and pyrazolo[4,3-d]pyrimidines. I].
    Baraldi PG; Vicentini CB; Simoni D; Guarneri M
    Farmaco Sci; 1983 Jun; 38(6):370-5. PubMed ID: 6603373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancerostatica. I. synthesis of some pyrazolo[1,5-a]pyrimidine and pyrazolo [3,4-b] pyridine derivatives.
    Nantka-Namirski P; Kaczmarek L
    Pol J Pharmacol Pharm; 1978; 30(4):563-8. PubMed ID: 740557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and antiinflammatory activity of 7-oxo-1H,7H-pyrazolo[1,5-a]pyrimidine-6-N-pyridylcarboxamides.
    Doria G; Passarotti C; Sala R; Magrini R; Sberze P; Tibolla M; Buttinoni A; Ferrari M; Tremolada L
    Farmaco Sci; 1985 Nov; 40(11):808-17. PubMed ID: 4085643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pyrazolo[3,4-d]pyrimidines as potent inhibitors of the insulin-like growth factor receptor (IGF-IR).
    Hubbard RD; Bamaung NY; Palazzo F; Zhang Q; Kovar P; Osterling DJ; Hu X; Wilsbacher JL; Johnson EF; Bouska J; Wang J; Bell RL; Davidsen SK; Sheppard GS
    Bioorg Med Chem Lett; 2007 Oct; 17(19):5406-9. PubMed ID: 17689078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and antitumor properties of pyrazolo [3,4-D] pyrimidine derivatives.
    Witkiewicz K; Machoń Z; Mordarski M; Wieczorek J
    Pol J Pharmacol Pharm; 1987; 39(6):715-20. PubMed ID: 3503990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis of 1H-pyrazolo[4,3-d]pyrimidine-7(6H)-ones and pyrazolo-5-carboxamides and interaction with benzodiazepine and adenosine A1 receptors in rat cerebral cortex.
    Baraldi PG; Casolari A; Manfredini S; Periotto V; Zanirato V; Florio C; Traversa V; Bertelli GM; Borea PA
    Arzneimittelforschung; 1988 Sep; 38(9):1262-5. PubMed ID: 2852012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and antihypertensive activity of novel 1-(4-benzyl-1-phthalazinyl)-pyrazolo[3,4-d]pyrimidines.
    el-Feky SA; Abd el-Samii ZK
    Pharmazie; 1996 Aug; 51(8):540-3. PubMed ID: 8794464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, synthesis, and biological evaluation of C9- and C2-substituted pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidines as new A2A and A3 adenosine receptors antagonists.
    Baraldi PG; Fruttarolo F; Tabrizi MA; Preti D; Romagnoli R; El-Kashef H; Moorman A; Varani K; Gessi S; Merighi S; Borea PA
    J Med Chem; 2003 Mar; 46(7):1229-41. PubMed ID: 12646033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and pharmacological properties of derivatives of isoxazolo[4,3-d]pyrimidine. III.
    Wagner E; Poreba K; Jakowicz I; Balicka D; Rutkowska M; Kedzierska-Goździk L; Szelag A
    Farmaco; 1995 Mar; 50(3):183-7. PubMed ID: 7755866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and biological evaluation of novel pyrazoles and pyrazolo[3,4-d]pyrimidines incorporating a benzenesulfonamide moiety.
    Ashour HM; Wahab AE
    Arch Pharm (Weinheim); 2009 Apr; 342(4):238-52. PubMed ID: 19340837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiallergic activity of alkyl substituted pyrazolo[3, 4-d]pyrimidine (compound 88-765).
    Gupta PP; Srimal RC; Avasthi K; Garg N; Chandra T; Bhakuni DS
    Indian J Exp Biol; 1995 Jan; 33(1):38-40. PubMed ID: 9135673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of 2,3-diaryl-pyrazolo[1,5-b]pyridazines as potent and selective cyclooxygenase-2 inhibitors.
    Beswick P; Bingham S; Bountra C; Brown T; Browning K; Campbell I; Chessell I; Clayton N; Collins S; Corfield J; Guntrip S; Haslam C; Lambeth P; Lucas F; Mathews N; Murkit G; Naylor A; Pegg N; Pickup E; Player H; Price H; Stevens A; Stratton S; Wiseman J
    Bioorg Med Chem Lett; 2004 Nov; 14(21):5445-8. PubMed ID: 15454242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and some central pharmacological properties of new derivatives of 2,3-dihydroimidazo[1,2-a]pyrimidine-6-carboxylic acid.
    Matosiuk D; Tkaczyński T; Jagiełło-Wójtowicz E; Zebrowska-Lupina I; Czuczwar SJ; Matuszek B; Klenk-Majewska B; Danilczuk Z; Janusz W; Kleinrok Z
    Pol J Pharmacol Pharm; 1992; 44(1):67-78. PubMed ID: 1437853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determination of permeability and lipophilicity of pyrazolo-pyrimidine tyrosine kinase inhibitors and correlation with biological data.
    Dreassi E; Zizzari AT; Falchi F; Schenone S; Santucci A; Maga G; Botta M
    Eur J Med Chem; 2009 Sep; 44(9):3712-7. PubMed ID: 19410338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.